CureDuchenne Venture's Early Stage Investment in Bamboo Therapeutics Accelerates Gene Therapy for Duchenne ... - Business Wire (press release)

CureDuchenne Venture's Early Stage Investment in Bamboo Therapeutics Accelerates Gene Therapy for Duchenne ... Business Wire (press release) NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Today, Pfizer Inc. announced its acquisition of Bamboo Therapeutics in a deal worth up to $645 million. Bamboo Therapeutics is an early-stage biotechnology company developing therapies for rare ... and more »

CureDuchenne Venture's Early Stage Investment in Bamboo Therapeutics Accelerates Gene Therapy for Duchenne ... - Business Wire (press release)
Read More